no it’s not similar as the phase 2 had a single primary end point for inflammatory lesions. Now non inflammatory will be included as an endpoint which was the biggest home run of the lot in phase 2.
while inflammatory may be a 50/50 in phase 3, non inflammatory may just be the added element to take us through to market.
so happy with that after the outcomes of the past 6 months
Ann: BTX 1503 End of Phase 2 Milestone with FDA, page-16
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
-0.008(2.11%) |
Mkt cap ! $628.9M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.5¢ | 34.5¢ | $453.5K | 1.299M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 718140 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 327897 | 7 |
View Market Depth
| Last trade - 10.41am 28/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |